50
Participants
Start Date
June 30, 2005
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2006
caspofungin acetate
Cancidas 50 mg dose followed by 70 mg load on day 1 was administered in Indian adults with persistent fever and neutropenia for a maximum duration of empirical treatment from 28 days ((for patients without documented infection) to 90 days (for patients with documented baseline or emergent fungal infection). Patients were treated until the resolution of neutropenia (ANC\>500/mm3), and for up to 72 hours later.
Merck Sharp & Dohme LLC
INDUSTRY